Resistance to key malaria drug spreading at alarming rate in Southeast Asia
3 institutional releases
Published in New England Journal of Medicine · View the paper (DOI)
Artemisinin resistance has become widespread in Southeast Asia, particularly in Cambodia, Myanmar, Thailand, and Vietnam. A six-day course of artemisinin-based combination therapy proved highly effective in treating drug-resistant malaria cases.
Coverage from 3 institutions
- Resistance to key malaria drug spreading at alarming rate in Southeast Asia NIH/National Institute of Allergy and Infectious Diseases · Jul 30, 2014 · first to report
- Drug-resistant malaria has spread to critical border regions of Southeast Asia Wellcome Trust · Jul 30, 2014
- Study in Myanmar confirms artemisinin-resistant malaria close to border with India Wellcome Trust · Feb 19, 2015